EACS2023: 584 Integrated assessment and management of non-communicable diseases (NCDs): a survey of HIV centers in the WHO European Region C. Kraef , S. Singh , O. Fursa , A. Abutidze , N. Rukhadze , V. Mulabdic , N. Yancheva , M. Mehmeti , T. Balayan , A. Harxhi , J. Trajanovska , C. Mackintosh , C. Duvivier, M. Beniowski , D. Jilich , D.H. Reikvam , L. Tau , D. Podlekareva , L. Ryom , L. Peters , J. Kowalska , O. Kirk CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia, Clinic for Infectious Diseases University Clinical Center Sarajevo, Sarajevo, Bosnia and Herzegovina, Specialized Hospital for Active Treatment of Infectious and Parasitic Diseases, Sofia, Bulgaria, Department of Infectious Diseases, University Clinical Centre, Pristina, Kosovo, National Center for Disease Control and Prevention, Yerevan, Armenia, Infectious Disease Service, HIV ambulatory clinic, Tirana, Albania, University clinic for infectious diseases & febrile conditions, Skopje, North Macedonia, The Republic of, Western General Hospital, Edinburgh, United Kingdom, Diagnostics and Therapy for AIDS, Specialistic Hospital, Chorzów, Poland, Charles University in Prague and Na Bulovce Hospital, Prague, Czech Republic, Dep. of Infectious diseases, Oslo University Hospital, Oslo, Norway, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel, Department of Respiratory Medicine and Infectious Diseases – Bispebjerg, Copenhagen University Hospital, Copenhagen, Denmark, Department of Infectious Diseases, Hvidovre University Hospital, Copenhagen, Denmark, Hospital for Infectious Diseases, Medical University of Warsaw, Warsaw, Poland General data Abstract category: Access and delivery of care Abstract body Purpose: People with HIV (PWH) are disproportionally affected by non-communicable diseases (NCD) compared to the general population. We aimed to assess the extent of integration of NCD assessment and management in HIV clinics across Europe. Method: A structured electronic questionnaire with 41 multiple-choice and rating-scale questions assessing NCD assessment and management was sent to an established network of 85 HIV clinics (EuroSIDA) across the WHO European Region in March - May 2023. One response per clinic, preferably by the most senior clinician, was collected. Results: 51 clinics from 34 countries, evenly distributed across Europe, with >100,000 PWH under active follow-up responded to the survey. 37 clinics (72.6%) reported shared NCD-care responsibility with the PWH’s general practitioner. Systematic assessment of PWH for NCDs was common overall (median 80%;IQR 55–95%) (Figure 1). Integration of NCD management was also common overall (70%;IQR 50-88%), however lowest in east central Europe (50%; 32–89%) and eastern Europe (50%;IQR 40–54.5%) (Figure 1). PWH ≥50 years (n=38/51, 74.5%) and those with chronic hepatitis B and/or C co-infection (n=28/51, 54.9%) were prioritized for NCD screening and care. Chronic kidney disease (median 96%;IQR 85–100%), and metabolic disorders (90%;IQR 75–100%) were often systematically assessed, while mental health (72%;IQR 63-85%) and pulmonary diseases (52%;IQR 40-75%) were least systematically assessed (Figure 2). The most frequent barriers reported for integrating NCD care were the lack of health care workers (n=17/51; 33.3%) and the lack of time during outpatient visits (n=12/51; 23.5%). Conclusions: HIV clinics in Europe are systematically assessing and managing NCDs. There are, however, larger gaps among eastern European clinics and for mental health and pulmonary diseases in general. More human resources and time during outpatient visits could help attenuate that gap. Figure 1. Systematic NCD-assessment(blue) and integrated NCD-management(red)(rating-scale 0–100%), by European region. Figure 2. Assessment of NCDs(rating-scale 0–100%). General conditions 1. I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after the submission deadline and I am aware that it will be published exactly as submitted.: Yes 2. I confirm that the submission of the abstract constitutes my consent to publication (e.g. conference website, programmes, other promotions, etc.). : Yes 3. I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.: Yes 4. I agree that all data provided may be used (saved, stored, processed, transmitted and deleted) in compliance with the privacy policy to provide the services described.: Yes 1,2 1 1 3 3 4 5 6 7 8 9 10 11 12 13 14 1,15 1,16 1 17 1,2 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 27
RkJQdWJsaXNoZXIy Mzc2ODc=